Adial Pharmaceuticals Stock Alpha and Beta Analysis
| ADIL Stock | USD 1.00 0.01 0.99% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Adial Pharmaceuticals. It also helps investors analyze the systematic and unsystematic risks associated with investing in Adial Pharmaceuticals over a specified time horizon. Remember, high Adial Pharmaceuticals' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Adial Pharmaceuticals' market risk premium analysis include:
Beta 0.12 | Alpha (0.04) | Risk 3.78 | Sharpe Ratio 0.0222 | Expected Return 0.0841 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Adial |
Adial Pharmaceuticals Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Adial Pharmaceuticals market risk premium is the additional return an investor will receive from holding Adial Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Adial Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Adial Pharmaceuticals' performance over market.| α | -0.04 | β | 0.12 |
Adial Pharmaceuticals expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Adial Pharmaceuticals' Buy-and-hold return. Our buy-and-hold chart shows how Adial Pharmaceuticals performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Adial Pharmaceuticals Market Price Analysis
Market price analysis indicators help investors to evaluate how Adial Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Adial Pharmaceuticals shares will generate the highest return on investment. By understating and applying Adial Pharmaceuticals stock market price indicators, traders can identify Adial Pharmaceuticals position entry and exit signals to maximize returns.
Adial Pharmaceuticals Return and Market Media
The median price of Adial Pharmaceuticals for the period between Thu, Aug 29, 2024 and Wed, Nov 27, 2024 is 1.01 with a coefficient of variation of 4.76. The daily time series for the period is distributed with a sample standard deviation of 0.05, arithmetic mean of 1.02, and mean deviation of 0.04. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Adial Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference | 09/04/2024 |
2 | Acquisition by Newman James W. Jr. of 50000 shares of Adial Pharmaceuticals at 0.3025 subject to Rule 16b-3 | 10/01/2024 |
3 | Adial Pharmaceuticals Commends the National Institute on Alcohol Abuse and Alcoholisms New Definition of Recovery | 10/15/2024 |
4 | EXCLUSIVE Adial Pharmaceuticals Secures Additional US Patent Expanding Intellectual Property Protection Around Its Alcohol Use Disorder Candidate | 10/17/2024 |
5 | Adial Pharmaceuticals appoints Vinay Shah as CFO | 11/05/2024 |
6 | ARMISTICE CAPITAL, LLC Acquires New Stake in Adial Pharmaceuticals Inc | 11/15/2024 |
7 | Adial Pharmaceuticals Upgraded to Buy Heres What You Should Know | 11/25/2024 |
About Adial Pharmaceuticals Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Adial or other stocks. Alpha measures the amount that position in Adial Pharmaceuticals has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Adial Pharmaceuticals Upcoming Company Events
As portrayed in its financial statements, the presentation of Adial Pharmaceuticals' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Adial Pharmaceuticals' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Adial Pharmaceuticals' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Adial Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Adial Pharmaceuticals' management manipulating its earnings.
| 4th of April 2024 Upcoming Quarterly Report | View | |
| 10th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 4th of April 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Adial Pharmaceuticals
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Adial Pharmaceuticals Backtesting, Adial Pharmaceuticals Valuation, Adial Pharmaceuticals Correlation, Adial Pharmaceuticals Hype Analysis, Adial Pharmaceuticals Volatility, Adial Pharmaceuticals History and analyze Adial Pharmaceuticals Performance. For more information on how to buy Adial Stock please use our How to buy in Adial Stock guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.
Adial Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.